Compatibility and stability of non-ionic iodinated contrast media in peritoneal dialysis solution and safe practice considerations for CT peritoneography
Open Access
- 3 May 2022
- journal article
- research article
- Published by SAGE Publications in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
- Vol. 43 (2) , 151-158
Abstract
Background: Computerised tomographic (CT) peritoneography is performed on peritoneal dialysis (PD) patients to identify peritoneal boundary defects, dialysate maldistributions and loculated fluid collections. Iodinated contrast media are added to dialysate and infused through the dialysis catheter, and CT images are obtained. Chemical compatibility of contrast media with dialysis solutions has not been studied. In some institutions, pharmacists charged with oversight of compounded sterile preparations have placed a moratorium on the use of contrast media-dialysate mixtures until compatibility data become available. This study was undertaken to examine the compatibility of non-ionic iodinated contrast agents added to PD solution for the performance of CT peritoneography. Methods: 100 mL of three non-ionic iodinated contrast agents, iopamidol 370 mgI/mL, iohexol 300 mgI/mL and iodixanol 320 mgI/mL, were mixed with 2 L 1.5% dextrose PD solution and stored at 2–8°C, 25°C and 40°C. Observations at predefined intervals were made over 5 days for visual appearance, turbidity, pH, drug concentration and chemical degradation. Results: Iopamidol, iohexol and iodixanol were stable for 5 days under study conditions. The contrast-dialysate mixture remained clear and colourless, no turbidity changes observed, pH and drug concentrations were stable and no increase in existing impurities or new impurities were detected. Conclusions: The addition of commonly used non-ionic iodinated contrast agents to 1.5% dextrose dialysis solution is chemically stable, meeting the criteria set forth in the standards and guidelines of the US Pharmacopeia and the Institute of Safe Medication Practices. A protocol for performing CT peritoneography is recommended herein to facilitate patient safety and diagnostic reliability of the imaging study.Keywords
Funding Information
- Baxter Healthcare Corporation, Deerfield, IL, USA
This publication has 28 references indexed in Scilit:
- Canadian Association of Radiologists Consensus Guidelines for the Prevention of Contrast-Induced Nephropathy: Update 2012Canadian Association of Radiologists Journal, 2014
- Contrast-induced kidney injury: mechanisms, risk factors, and preventionEuropean Heart Journal, 2012
- Pathophysiology of renal tissue damage by iodinated contrast mediaClinical and Experimental Pharmacology and Physiology, 2011
- The Relative Renal Safety of Iodixanol Compared With Low-Osmolar Contrast MediaJACC: Cardiovascular Interventions, 2009
- Complications of Continuous Ambulatory Peritoneal DialysisRadioGraphics, 2009
- Pleuroperitoneal communication of peritoneal dialysis demonstrated by multidetector-row CT peritoneographyAbdominal Radiology, 2008
- Complications of peritoneal dialysis: evaluation with CT peritoneography.RadioGraphics, 1997
- Complications of continuous ambulatory peritoneal dialysis: evaluation with CT peritoneography.American Journal of Roentgenology, 1992
- Computed tomographic peritoneography in the investigation of abdominal wall and genital swelling in patients on continuous ambulatory peritoneal dialysisClinical Radiology, 1990
- CT peritoneography in evaluation of pediatric dialysis complicationsAmerican Journal of Roentgenology, 1986